Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blis

Published by Reclia Safety Desk | July 15, 2026

Recall Information Record – Reclia Database

Recall Summary
On April 10, 2025, Kramer Laboratories, a subsidiary of Arcadia Consumer Healthcare of Bridgewater, New Jersey, initiated a recall of Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. The recall was issued due to a violation of the federal regulation for child-resistant packaging under the Poison Prevention Packaging Act. The recall notice was published by the U.S. Consumer Product Safety Commission (CPSC) under Recall Number 25223. No injuries have been reported in connection with this recall.

Affected Products
The recalled product is Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets sold in 24-count blister packs. The packaging is labeled with “Safetussin,” “Multi-Symptom,” “Cough, Cold & Flu,” and “Safe for adults with High Blood Pressure, Diabetes.” The product is packaged in a blue, orange, and red cardboard box with the drug facts label on the back. The recalled units were sold at HEB, Harris-Teeter, and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for approximately $11. The number of units affected is about 14,250. The product was manufactured in India. Specific model numbers, types, or UPCs are not specified in the recall notice.

Hazard Information
The hazard involves the product’s packaging. The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the recalled products is not child-resistant because a tablet can be pushed through the foil. This poses a risk of poisoning if the contents are swallowed by young children. No injuries have been reported as of the recall date.

Consumer Action Required
Consumers should immediately secure the recalled product out of the sight and reach of children. Consumers should then contact Kramer Laboratories for information on how to return or dispose of the product. The recall notice specifies that only the packaging is being recalled, not the medicine itself, but both the packaging and the medicine should be disposed of. Consumers are directed to follow the instructions provided by Kramer Laboratories for proper disposal or return.

Official Remedy
The official remedy offered by Kramer Laboratories is a full refund. Consumers are instructed to contact the company for information on how to return or dispose of the product in order to receive the refund.

Contact Information
Consumers may contact Kramer Laboratories by phone at 800-824-4894, Monday through Friday from 8 a.m. to 5 p.m. ET. Alternatively, consumers may email the company at kramerlabs@emersongroup.com. Additional information is available online at https://safetussin.com/recall.

Frequently Asked Questions